Why the study?
Does the Baylor C-Gyro Pump Eccentric Inlet Port Model demonstrate antithrombogenicity in a calf model?
Population
Calf model for in vivo experiment
Design
Preclinical
Follow-up
up to 18 days
Authors
Loading...
Supports further C1E pump development in animals; leaves open translation to durable human VADs.
Does the Baylor C-Gyro Pump Eccentric Inlet Port Model demonstrate antithrombogenicity in a calf model?
The Baylor C-Gyro Pump Eccentric Inlet Port Model demonstrated excellent antithrombogenicity in an initial 18-day in vivo calf experiment, supporting its potential as a long-term ventricular assist device.
Ohara et al. (1994) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: